semaglutide body composition GLP-1 and Muscle Loss: Semaglutide, Tirzepatide & Lean Mass Body Composition Changes from Semaglutide
Description
Billon 2023 (ACS Chemical Biology) Preclinical in vivo, 15-28 days, C57BL/6J mice (n = 8-10 per group)
Knowing which foods to avoid during GLP-1 protocols helps prevent triggering or worsening nausea
Symptoms can include sweating, dizziness, confusion, and in severe cases, loss of consciousness
Patients should confirm whether medications are dispensed from licensed 503A pharmacies and whether potency testing is documented
The results indicate that retatrutide has an overall safety and tolerability profile similar to other nutrient-stimulated hormone-based therapies, such as GLP-1 receptor agonists approved for obesity treatment
They also noted that both gluten and soy protein similarly increased GLP-1 secretion
